Environmental Burkholderia cepacia complex isolates in human infections

被引：103
作者：
Baldwin, Adam
Mahenthiralingam, Eshwar
Drevinek, Pavel
Vandamme, Peter
Govan, John R.
Waine, David J.
LiPuma, John J.
Chiarini, Luigi
Dalmastri, Claudia
Henry, Deborah A.
Speert, David P.
Honeybourne, David
Maiden, Martin C. J.
Dowson, Chris G. [1 ]
机构：
[1] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England
[2] Cardiff Univ, Cardiff, Wales
[3] Univ Ghent, B-9000 Ghent, Belgium
[4] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland
[5] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA
[6] Ente Nuove Tecnol Energia & Ambiente Casaccia, Rome, Italy
[7] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[8] Birmingham Heartlands Hosp, Birmingham, W Midlands, England
[9] Univ Oxford, Oxford, England
来源：
EMERGING INFECTIOUS DISEASES | 2007年 / 13卷 / 03期
基金：
英国惠康基金;
关键词：
D O I：
10.3201/eid1303.060403
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Members of the Burkholderia cepacia complex (Bcc), found in many environments, are associated with clinical infections. Examining diverse species and strains from different environments with multilocus sequence typing, we identified > 20% of 381 clinical isolates as indistinguishable from those in the environment. This finding links the natural environment with the emergence of many Rcc infections.
引用
收藏
页码：458 / 461
页数：4
相关论文
共 15 条
  • [1] Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex
    Baldwin, A
    Mahenthiralingam, E
    Thickett, KM
    Honeybourne, D
    Maiden, MCJ
    Govan, JR
    Speert, DP
    LiPuma, JJ
    Vandamme, P
    Dowson, CG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) : 4665 - 4673
  • [2] Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe
    Coenye, T
    Spilker, T
    Van Schoor, A
    LiPuma, JJ
    Vandamme, P
    [J]. THORAX, 2004, 59 (11) : 952 - 954
  • [3] Updated version of the Burkholderia cepacia complex experimental strain panel
    Coenye, T
    Vandamme, P
    LiPuma, JJ
    Govan, JRW
    Mahenthiralingam, E
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (06) : 2797 - 2798
  • [4] Taxonomy and identification of the Burkholderia cepacia complex
    Coenye, T
    Vandamme, P
    Govan, JRW
    Lipuma, JJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (10) : 3427 - 3436
  • [5] Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center:: a 7-year study
    Cunha, MV
    Leitao, JH
    Mahenthiralingam, E
    Vandamme, P
    Lito, L
    Barreto, C
    Salgado, MJ
    Sá-Correia, I
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (09) : 4113 - 4120
  • [6] EVIDENCE FOR TRANSMISSION OF PSEUDOMONAS-CEPACIA BY SOCIAL CONTACT IN CYSTIC-FIBROSIS
    GOVAN, JRW
    BROWN, PH
    MADDISON, J
    DOHERTY, CJ
    NELSON, JW
    DODD, M
    GREENING, AP
    WEBB, AK
    [J]. LANCET, 1993, 342 (8862) : 15 - 19
  • [7] Govan JRW, 2000, ASM NEWS, V66, P124
  • [8] Agricultural use of Burkholderia (Pseudomonas) cepacia: A threat to human health?
    Holmes, A
    Govan, J
    Goldstein, R
    [J]. EMERGING INFECTIOUS DISEASES, 1998, 4 (02) : 221 - 227
  • [9] Home-use nebulizers: A potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis
    Hutchinson, GR
    Parker, S
    Pryor, JA
    DuncanSkingle, F
    Hoffman, PN
    Hodson, ME
    Kaufmann, ME
    Pitt, TL
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) : 584 - 587
  • [10] An epidemic Burkholderia cepacia complex strain identified in soil
    LiPuma, JJ
    Spilker, T
    Coenye, T
    Gonzalez, CF
    [J]. LANCET, 2002, 359 (9322) : 2002 - 2003
12